Brief: T2 Biosystems Postpones Q1 2023 Earnings Release
15/05/2023 22:53
May 15 (Reuters) - T2 Biosystems Inc TTOO.O :
* T2 BIOSYSTEMS INC - POSTPONED ITS Q1 2023 EARNINGS RELEASE
AND
CONFERENCE CALL.
* T2 BIOSYSTEMS INC - DELAY IS A RESULT OF ADDITIONAL TIME
REQUIRED TO FINALIZE FILING OF COMPANY'S SEC FORM 10-Q.
Source text for Eikon: ID:nGNX42hYfn
Further company coverage: TTOO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on T2 Biosystems
See all newsBrief: T2 Biosystems Announces Intent To Wind Down Operations
Brief: T2 Biosystems Enters Amendment No. 12 To Term Loan Agreement
Brief: T2 Biosystems Announces Exclusive US Agreement With Cardinal Health To Sell Its FDA-Cleared Direct-From-Blood Diagnostics For Rapid Detection Of Sepsis-Causing Pathogens
T2 Biosystems Inc reports results for the quarter ended in June - Earnings Summary
Brief: T2 Biosystems Announces Commercial Expansion Through Malaysia And Indonesia Distributor